Development of cyclopeptide inhibitors specifically disrupting FXR–coactivator interaction in the intestine as a novel therapeutic strategy for MASH
Cited by 4
Related Papers
Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells
|The Journal of Cell Biology|2004|218
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
|Journal of Medicinal Chemistry|2017|147
Bioinspired large Stokes shift small molecular dyes for biomedical fluorescence imaging
|Science Advances|2022|122
Gene repression via multiplex gRNA strategy in Y. lipolytica
|Microbial Cell Factories|2018|72